At present it also remains unclear whether ECM-CD44 engagement drives stemness phenotypes, or whether the engagement of already upregulated CD44 ligands with ECM components such as hyaluronan preferentially supports cancer cells with stem-like phenotypes. The gene discussed is CD44; the disease is cancer.